Research Progress on Molecular Targeted Therapy of Non-small Cell Lung Cancer Combined with Traditional Chinese Medicine
Non-small cell lung cancer(NSCLC)is the most common type of lung cancer,and targeted therapy is the preferred treatment option for NSCLC.Despite significant progress in targeted drug therapy for NSCLC,there are still limitations due to tumor heterogeneity and tumor cell escape mechanisms.Therefore,more and more attention has been paid to the study of traditional Chinese medicine combined with targeted drug therapy in the treatment of NSCLC.This article summarizes the research on traditional Chinese medicine combined with targeted therapy in the field of NSCLC,in order to provide a theoretical basis for the combination therapy of traditional Chinese medicine and targeted therapy for NSCLC.
Targeted therapySyndrome differentiation and treatmentGene mutationInhibitor
国家科技期刊平台
NSTL
万方数据
